SH-273 News

Latest Articles

• University of Michigan Researchers Develop Dual-Action Compound SH-273 to Combat Immunotherapy Resistance in Pancreatic Cancer

  Published: Apr 30, 2026

  Section: Natural Sciences

  A scientific team at Michigan Medicine has engineered a new drug molecule, SH-273, designed to bypass the complex immune suppression that makes pancreatic cancer so difficult to tr...